Ultraviolet Radiation and Incidence of Non-Hodgkin's Lymphoma among Hispanics in the United States

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 1, 2004, Pages 59-64

  Hu, Shasa ^a   Ma, Fangchao ^c   Collado Mesa, Fernando ^a   Kirsner, Robert S ^a,b,c,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RISK; CORRELATION ANALYSIS; ENVIRONMENTAL RADIOACTIVITY; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SOLAR RADIATION; ULTRAVIOLET RADIATION; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; REGISTRIES; SEX DISTRIBUTION; ULTRAVIOLET RAYS; UNITED STATES;

EID: 1642487214     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-03-0187     Document Type: Article

References (57)

1. Kirsner, R. S., and Federman, D. G. The epidemiology of non-Hodgkin's lymphoma. Conn. Med., 60: 579-582, 1996.
2. Cartwright, R., McNally, R., and Staines, A. The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leuk. Lymphoma, 14: 387-394, 1994.
3. Devesa, S. S., and Fears, T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res., 52: 5432s-5440s, 1992.
4. Parkin, D. M., and Muir C. S. Cancer incidence in five continents. Comparability and quality of data. IARC Sci. Publ., 120: pp. 45-173. Lyon: IARC, 1992.
5. Clarke, C. A., and Glaser, S. L. Changing incidence of non-Hodgkin's lymphomas in the United States. Cancer (Phila.), 94: 2015-2023, 2002.
6. Bray, I., Brennan, P., and Boffetta, P. Recent trends and future projections of lymphoid neoplasms: a Bayesian age-period-cohort analysis. Cancer Causes Control, 12: 813-820, 2001.
7. National Cancer Institute. Cancer Statistics Review 1973-1987. Bethesda, Maryland: NIH, 1990.
8. Davis, D. L., Hoel, D., Fox, J., and Lopez, A. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet, 336: 474-481, 1990.
9. Tajima, K. Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL). Cancer Metastasis Rev., 7: 223-241, 1988.
10. Doll, R. Nature and nurture: possibilities for cancer control. Carcinogenesis (Lond.), 17: 177-184, 1996.
11. Baris, D., and Zahm, S. H. Epidemiology of lymphomas. Curr. Opin. Oncol., 12: 383-394, 2000.
12. Mueller, N. Overview of the epidemiology of malignancy in immune deficiency. J. Acquir. Immune. Defic. Syndr., 21 (Suppl. 1): S5-S10, 1999.
13. Mueller, N. Another view of the epidemiology of non-Hodgkin's lymphoma. Oncology (Huntingt.), 8: 83, 1994.
14. Zheng, T., Mayne, S. T., Boyle, P., Holford, T. R., Liu, W. L., and Flannery, J. Epidemiology of non-Hodgkin's lymphoma in Connecticut, 1935-1988. Cancer (Phila.), 70: 840-849, 1992.
15. Green, M. H., Petit-Frere, C., Clingen, P. H., Bentham, G., Cole, J., and Arlett, C. F. Possible effects of sunlight on human lymphocytes. J. Epidemiol., 9: S48-S57, 1999.
16. Kripke, M. L. Ultraviolet radiation and immunology: something new under the sun - presidential address. Cancer Res., 54: 6102-6105, 1994.
17. Goettsch, W., Garssen, J., de Gruijl, F. R., and van Loveren, H. UV-B and the immune system. A review with special emphasis on T-cell-mediated immunity. Thymus, 21: 93-114, 1993.
18. Miller, B., Kolonel, L. N., Bemstein, L., Young, J. L., Swanson, G. M., West, D., et al. Racial/Ethnic Patterns of Cancer in the United States, 1988-1992. Bethesda, MD: National Cancer Institute, 1996.
19. Ries, L., Eisner, M. P., Kosary, C. L., Hankey, B. F., Miller, B. A., Clegg, L., et al. (eds). SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute, 2003.
20. McMichael, A. J., and Giles, G. G. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br. J. Cancer, 73: 945-950, 1996.
21. Hall, P., Rosendahl, I., Mattsson, A., and Einhom, S. Non-Hodgkin's lymphoma and skin malignancies: shared etiology? Int. J. Cancer, 62: 519-522, 1995.
22. Hartge, P., Devesa, S. S., Grauman, D., Fears, T. R., and Fraumeni, J. F., Jr. Non-Hodgkin's lymphoma and sunlight. J. Natl. Cancer Inst. (Bethesda), 88: 298-300, 1996.
23. Adami, J., Frisch, M., Yuen, J., Glimelius, B., and Melbye, M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ, 310: 1491-1495, 1995.
24. Adami, J., Gridley, G., Nyren, O., Dosemeci, M., Linet, M., Glimelius, B., et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int. J. Cancer, 80: 641-645, 1999.
25. Bentham, G. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. BMJ, 312: 1128-1131, 1996.
26. Freedman, D. M., Zahm, S. H., and Dosemeci, M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. BMJ, 314: 1451-1455, 1997.
27. Newton, R. Non-Hodgkin's lymphoma and skin cancer. American data refute ultraviolet hypothesis. BMJ, 311: 750-751, 1995.
28. Goggins, W. B., Finkelstein, D. M., and Tsao, H. Evidence for an association between cutaneous melanoma and non-Hodgkin's lymphoma. Cancer (Phila.), 91: 874-880, 2001.
29. McKenna, D. B., Stockton, D., Brewster, D. H., and Doherty, V. R. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br. J. Cancer, 88: 74-78, 2003.
30. Riou, J. P., Ariyan, S., Brandow, K. R., and Fielding, L. P. The association between melanoma, lymphoma, and other primary neoplasms. Arch. Surg., 130: 1056-1061, 1995.
31. Department of Health and Human Services. Report of the Secretary's Task Force on Black and Minority Health, Vol. III (Cancer). Washington, DC: U. S. Government Printing Office, 1986.
32. Trapido, E. J., Burciaga Valdez, R., Obeso, J. L., Strickman-Stein, N., Rotger, A., and Perez-Stable, E. J. Epidemiology of cancer among Hispanics in the United States. J. Natl. Cancer Inst. Monogr., 18: 17-28, 1995.
33. Wolfgang, P. E., Semeiks, P. A., and Burnett, W. S. Cancer incidence in New York City Hispanics, 1982 to 1985. Ethn. Dis., 1: 263-272, 1991.
34. Therrien, M., and Ramirez, R. The Hispanic Population the United States: March 2000, Current Population Reports. Washington DC: U. S. Census Bureau, 2000.
35. U. S. Census Bureau Population Division. Projections of the Resident Population by Race, Hispanic Origin, and Nativity: Middle Series, 1999 to 2100. Washington, DC: U. S. Census Bureau, 2000.
36. U. S. Census Bureau. Census 2000 redistricting data (P. L. 94-171) summary file for states and census 2000 redistricting summary file for Puerto Rico, Tables PLI and PL 2. http://www.census.gov/population/cen2000/phc-t6/tab01.pdf, 2001.
37. North American Association of Central Cancer Registries. Cancer in North America 1996-2000: Registry-Specific Incidence by Sex and Race, Age-Adjusted to the 2000 and 1970 U. S. Standards. North American Association of Central Cancer Registries, 2000.
38. National Weather Service. Monthly mean UV index. http://www.cpc.ncep.noaa.gov/products/stratosphere/uv_index/uv_annual.html, 1997.
39. Burger, S., Agovino, P., Klotz, J. B., Abe, T., Van Loon, S., and Kohler, B. A. Cancer Incidence and Mortality in New Jersey 1996-2000. Trenton, NJ: New Jersey Department of Health and Senior Services, Cancer Epidemiology Services, New Jersey State Cancer Registry, 2002.
40. Florida Cancer Data System. Cancer Incidence 1989-1995. Miami, FL: Bureau of Epidemiology, Florida Department of Health and Florida Cancer Data System, 2003.
41. Weiss, N., Risser, D. R., and Williams, M. A. (eds). Cancer in Texas, 1998. Austin, TX: Texas Department of Health, 2002.
42. Texas Cancer Registry. Data Request No. 03177, 05/12/2003, SEER*Stat 1995-1999 Incidence File. Austin, TX: Texas Department of Health, 2003.
43. New York State Cancer Registry. Cancer incidence and mortality by gender and race, New York State, 1995-1999, http://www.health.state.ny.us/nysdoh/cancer/1999/2000/table5.pdf.New York: New York State Department of Health, New York State Cancer Registry, 2002.
44. Illinois State Cancer Registry. Illinois County Cancer Statistics Review Incidence, 1995-1999. Springfield, IL: Illinois Department of Public Health, Illinois State Cancer Registry, Division of Epidemiologic Studies, 2002.
45. Kwong, S., Perkins, C. I., Morris, C. R., Cohen. R., Allen, M., and Wright, W. E. Cancer in California, 1988-1999. Sacramento, CA: California Department of Health Services, 2001.
46. Ferlay, J., Bray, F., Pisani, P., and Parkin, D. M. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, version IARC CancerBase No. 5. http://www-dep.iarc.fr/globocan/globocan.ht, 2001.
47. Caligo, M. A. C. G., Petrini, M., Valentini, P., and Bevilacqua, G. Down-regulation of NM23, H1, NM23, H2 and c-myc genes during differentiation induced by 1,25 dihydroxyvitamin D3. Leuk. Res., 20: 161-167, 1996.
48. Bodiwala, D., Luscombe, C. J., French, M. E., Liu, S., Saxby, M. F., Jones, P. W., et al. Susceptibility to prostate cancer: studies on interactions between UVR exposure and skin type. Carcinogenesis (Lond.), 24: 711-717, 2003.
49. Luscombe, C. J., French, M. E., Liu. S., Saxby, M. F., Jones, P. W., Fryer, A. A., et al. Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes. Br. J. Cancer. 85: 1504-1509, 2001.
50. Luscombe, C. J., Fryer, A. A., French, M. E., Liu, S., Saxby, M. F., Jones, P. W., et al. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet, 358: 641-642, 2001.
51. Rego, M. A., Sousa, C. S., Kato, M., de Carvalho, A. B., Loomis, D., and Carvalho, F. M. Non-Hodgkin's lymphomas and organic solvents. J. Occup. Environ. Med., 44: 874-881, 2002.
52. Hardell, L., and Axelson, O. Environmental and occupational aspects on the etiology of non-Hodgkin's lymphoma. Oncol. Res., 10: 1-5, 1998.
53. Center for Disease Control and Prevention. HIV/AIDS Surveillance Report. Washington, DC: Center for Disease Control, 2001.
54. Organ Procurement and Transplantation Network. Transplants in the U. S. by state. http://www.optn.org/latestData/rptData.asp, 2003.
55. Mckinnon, J. The Black Population in the United States: March 2002. Washington, DC: U. S. Census Bureau, Current Population Reports, 2003.
56. Cancer Surveillance, Epidemiology, and End Results Reporting (SEER) Program 1973-1997. Bethesda, MD: U. S. Department of Health and Human Services, Public Health Service, NIH, 2000.
57. Groves, F. D., Linet, M. S., Travis, L. B., and Devesa, S. S. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J. Natl. Cancer Inst. (Bethesda), 92: 1240-1251, 2000.